| Literature DB >> 25707690 |
Wen-Tsong Hsieh, Ke-Rung Tzeng, Jin-Shuei Ciou, Jeffrey Jp Tsai, Nilubon Kurubanjerdjit, Chien-Hung Huang, Ka-Lok Ng.
Abstract
BACKGROUND: Molecular networks are the basis of biological processes. Such networks can be decomposed into smaller modules, also known as network motifs. These motifs show interesting dynamical behaviors, in which co-operativity effects between the motif components play a critical role in human diseases. We have developed a motif-searching algorithm, which is able to identify common motif types from the cancer networks and signal transduction networks (STNs). Some of the network motifs are interconnected which can be merged together and form more complex structures, the so-called coupled motif structures (CMS). These structures exhibit mixed dynamical behavior, which may lead biological organisms to perform specific functions.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25707690 PMCID: PMC4331680 DOI: 10.1186/1752-0509-9-S1-S5
Source DB: PubMed Journal: BMC Syst Biol ISSN: 1752-0509
A comparison of motif finding by the adjacency matrix approach and FANMOD
| approach | motif | AML | Glioma | Melanoma | NSCLC | PC | RCC |
|---|---|---|---|---|---|---|---|
| Adjacency Matrix | FFL | 1 | 1 | 1 | |||
| bi-fan | 1 | 1 | |||||
| FANMOD | FFL | 0 (FN) | 0 (FN) | 0 (FN) | |||
| bi-fan | 0 (FN) | 0 (FN) | |||||
| Non bi-fan | 2(2)* | 1(1)* | 0(0)* | 2(2)* | 3(3)* | 3(1)* | |
§given a fixed motif size, the italic and underlined fonts denote the results uisng adjacency matrix approach are consistent with those of FANMON, i.e. true positive or true negative events
* the first number denotes the number of identified motifs, the number inside the parenthesis denotes the total number of motif pattern found in the cancer type
| A The total number of the five motif types identified for cancer networks and STNs | |||||
|---|---|---|---|---|---|
| ARL | FBL | FFL | bi-fan | SIM | |
| Pathways in cancer | 0 | 0 | 1 | 73 | 27 |
| AML | 0 | 0 | 0 | 9 | 12 |
| Glioma | 0 | 0 | 0 | 9 | 6 |
| Melanoma | 0 | 0 | 0 | 1 | 4 |
| NSCLC | 0 | 1 | 2 | 4 | 7 |
| PC | 0 | 0 | 1 | 0 | 5 |
| RCC | 0 | 0 | 1 | 0 | 3 |
| Erbb | 0 | 0 | 5 | 69 | 17 |
| FoxO | 0 | 0 | 3 | 0 | 3 |
| Hippo | 0 | 0 | 2 | 0 | 8 |
| Jak-Stat | 0 | 0 | 0 | 4 | 3 |
| Mapk | 0 | 0 | 1 | 6 | 32 |
| PI3k-Akt | 0 | 0 | 1 | 1 | 10 |
| Rap1 | 0 | 0 | 0 | 1 | 13 |
| Ras | 0 | 0 | 2 | 15 | 18 |
| TGF_Beta | 0 | 0 | 0 | 1 | 7 |
| TNF | 0 | 0 | 0 | 1 | 11 |
| TCS | 0 | 0 | 0 | 3 | 35 |
| VEGF | 0 | 0 | 2 | 0 | 5 |
| Wnt | 0 | 0 | 11 | 0 | 7 |
| B The total number of SIM motifs identified in cancer networks and STNs | |||||
| SIM | |||||
| Basal cell carcinoma | 1 | ||||
| Bladder cancer | 1 | ||||
| Chronic myeloid leukemia | 4 | ||||
| Colorectal cancer | 4 | ||||
| Endometrial cancer | 4 | ||||
| Pancreatic cancer | 8 | ||||
| Small cell lung cancer | 2 | ||||
| 9 | |||||
| Calcium signaling | 3 | ||||
| Hedgehog | 6 | ||||
| HIF-1 | 6 | ||||
| mTOR | 10 | ||||
| NFkB | 2 | ||||
| Notch | 2 | ||||
| Phosphatidylinositol signaling system | |||||
Cancer-related motifs that are reported in literature
| Cancer | ARL | FBL | FFL | Bi-fan | SIM |
|---|---|---|---|---|---|
| AML | 0 | 0 | 0 | 20 | 62 |
| Glioma | 0 | 0 | 0 | 29 | 4 |
| Melanoma | 0 | 0 | 0 | 2 | 0 |
| NSCLC | 0 | 3 | 2 | 40 | 37 |
| PC | 0 | 0 | 2 | 0 | 4 |
| RCC | 0 | 0 | 20 | 0 | 22 |
The results of the six types of CMS for cancer networks and STNs
| FBL-FBL | FFL-FFL | bi-fan-bi-fan | FBL-FFL | FBL-bi-fan | FFL-bi-fan | size | max deg |
|
| |
|---|---|---|---|---|---|---|---|---|---|---|
| Cancer networks | ||||||||||
| AML | 0 | 0 | 17 | 0 | 0 | 0 | 22 | 7 | 0.310 | 0.116 |
| Glioma | 0 | 0 | 36 | 0 | 0 | 0 | 8 | 4 | 0.0443 | 0.393 |
| Melanoma | 0 | 0 | 0 | 0 | 0 | 0 | 4 | 2 | 0.0678 | 0.400 |
| NSCLC | 0 | 1 | 6 | 0 | 4 | 2 | 18 | 6 | 0.0309 | 0.150 |
| PC | 0 | 0 | 0 | 0 | 0 | 0 | 18 | 11 | 0.0137 | 0.111 |
| RCC | 0 | 0 | 0 | 0 | 0 | 0 | 6 | 5 | 0.0075 | 0.333 |
| Median, | 13 | 5.5 | 0.0376 | 0.242 | ||||||
| Signal transduction networks (STNs) | ||||||||||
| Erbb | 0 | 10 | 1607 | 0 | 0 | 111 | 31 | 13 | 0.0106 | 0.123 |
| FoxO | 0 | 2 | 0 | 0 | 0 | 0 | 34 | 31 | 0.00074 | 0.064 |
| Hippo | 0 | 10 | 0 | 0 | 0 | 0 | 12 | 6 | 0.0765 | 0.167 |
| Jak-Stat | 0 | 0 | 3 | 0 | 0 | 0 | 16 | 6 | 0.0461 | 0.158 |
| Mapk | 0 | 0 | 6 | 0 | 0 | 0 | 72 | 13 | 0.0154 | 0.039 |
| PI3k-Akt | 0 | 0 | 0 | 0 | 0 | 0 | 39 | 15 | 0.00878 | 0.058 |
| Rap1 | 0 | 0 | 0 | 0 | 0 | 0 | 26 | 15 | 0.0161 | 0.080 |
| Ras | 0 | 1 | 105 | 0 | 0 | 7 | 39 | 14 | 0.0107 | 0.082 |
| TGF_Beta | 0 | 0 | 0 | 0 | 0 | 0 | 5 | 3 | 0.0678 | 0.250 |
| TNF | 0 | 0 | 0 | 0 | 0 | 0 | 12 | 5 | 0.0379 | 0.167 |
| TCS | 0 | 0 | 3 | 0 | 0 | 0 | 11 | 8 | 0.0333 | 0.182 |
| VEGF | 0 | 1 | 0 | 0 | 0 | 0 | 19 | 8 | 0.0146 | 0.123 |
| Wnt | 0 | 24 | 0 | 0 | 0 | 0 | 24 | 9 | 0.0106 | 0.123 |
| Median, | 32.5 | 13.5 | 0.00158 | 0.081 | ||||||
| 2.50 | 2.46 | 0.419 | 0.335 | |||||||
Mirna-regulated cancer network motifs
| Cancer | miRNA | FBL | FFL | bi-fan |
|---|---|---|---|---|
| AML | 80 | 0 | 0 | 27/7 |
| Glioma | 133 | 0 | 0 | 7/0 |
| Melanoma | 131 | 0 | 0 | 8/1 |
| NSCLC | 92 | 6/0 | 1/0 | 13/1 |
| PC | 126 | 0 | 1/0 | 0 |
| RCC | 44 | 0 | 15/1 | 0 |
Figure 1TMMN for NSCLC network displayed using Cytoscape. Square node and hexagon denote miRNA and target gene respectively, Circular shape denotes transcription factor. Compound, and p+ represent compound and phosphorylation event respectively. Compound interaction denotes interaction with an intermediate molecule, mostly chemical compound.
The gene set enrichment analysis results for the AML network motifs
| Annotation cluster | Enrichment source | Involving genes | % of the total genes |
|---|---|---|---|
| GO_BP | cellular process | 15 | 93.75% |
| GO_CC | intracellular | 15 | 93.75% |
| GO_MF | protein binding | 15 | 93.75% |
| KEGG | Acute myeloid leukemia | 16 | 100.00% |
| KEGG | Pathways in cancer | 16 | 100.00% |
The gene set enrichment analysis results for the NSCLC network motifs
| Annotation cluster | Enrichment source | Involving genes | % of the total genes |
|---|---|---|---|
| KEGG | NSCLC | 10 | 100.00% |
| KEGG | ErbB signaling pathway | 9 | 90.00% |
| KEGG | Glioma | 8 | 80.00% |
| KEGG | Pathways in cancer | 9 | 90.00% |
The Jaccard index for crosstalking of six cancer networks and 13 stns
| AML | Glioma | Melanoma | NSCLC | PC | RCC | |
|---|---|---|---|---|---|---|
| Erbb | 0.090 | 0.103 | 0.096 | 0.173 | 0.167 | 0.109 |
| FoxO | 0.024 | 0 | 0.023 | 0.045 | 0.055 | 0.021 |
| Hippo | 0.026 | 0 | 0.025 | 0.016 | 0.019 | 0.022 |
| Jak-Stat | 0.082 | 0.024 | 0.076 | 0.083 | 0.066 | 0.082 |
| Mapk | 0.030 | 0.027 | 0.036 | 0.033 | 0.050 | 0.049 |
| PI3k-Akt | 0.096 | 0.046 | 0.103 | 0.132 | 0.184 | 0.072 |
| Rap1 | 0.037 | 0.051 | 0.034 | 0.044 | 0.036 | 0.032 |
| Ras | 0.082 | 0.038 | 0.089 | 0.096 | 0.088 | 0.073 |
| TGF_Beta | 0 | 0 | 0.015 | 0 | 0.022 | 0.027 |
| TNF | 0.014 | 0.020 | 0.013 | 0.034 | 0.019 | 0.024 |
| TCS | 0 | 0 | 0 | 0 | 0 | 0 |
| VEGF | 0.024 | 0.154 | 0.058 | 0.149 | 0.053 | 0.038 |
| Wnt | 0.052 | 0.018 | 0.049 | 0.031 | 0.067 | 0.056 |